Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation – Data from the Ljubljana Registry

BACKGROUND AND AIM: Interruption of anticoagulant treatment with warfarin or non-vitamin K antagonist oral anticoagulants (NOAC) represents a vulnerable period with an increased risk of thromboembolic events. What is the incidence of thromboembolic events in real-life patients with non-valvular atri...

Descripción completa

Detalles Bibliográficos
Autores principales: Vene, Nina, Mavri, Alenka, Gubenšek, Mirjam, Tratar, Gregor, Vižintin Cuderman, Tjaša, Pohar Perme, Maja, Blinc, Aleš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900606/
https://www.ncbi.nlm.nih.gov/pubmed/27280704
http://dx.doi.org/10.1371/journal.pone.0156943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900606/
https://www.ncbi.nlm.nih.gov/pubmed/27280704
http://dx.doi.org/10.1371/journal.pone.0156943

Ejemplares similares